Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cambrex Corp. (NYSE: CBM).

Full DD Report for CBM

You must become a subscriber to view this report.


Recent News from (NYSE: CBM)

Cambrex (CBM) Presents At 2018 Wells Fargo Securities Healthcare Conference - Slideshow
The following slide deck was published by Cambrex Corporation in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 05 2018 13:41
Cambrex Corporation (CBM) CEO Steven Klosk on Q2 2018 Results - Earnings Call Transcript
Cambrex Corporation (CBM) Q2 2018 Earnings Conference Call August 02, 2018 8:30 AM ET Executives Steven Klosk - President and Chief Executive Officer Tom Vadaketh - Executive Vice President and Chief Financial Officer Analysts James Rutherford - Stephens Inc. Matthew Hewitt...
Source: SeekingAlpha
Date: August, 03 2018 20:25
Cambrex beats by $0.08, beats on revenue
Cambrex (NYSE: CBM ): Q2 EPS of $0.74 beats by $0.08 . More news on: Cambrex Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 02 2018 06:45
Cambrex Reports Second Quarter 2018 Financial Results
- Net Revenue increased 13% vs. prior year quarter, which includes a favorable impact from the adoption of ASC 606 - - 2018 full year Adjusted Net Revenue Growth and Adjusted EBITDA guidance reaffirmed - - Agreement to acquire Halo Pharma, broadening capabilities, enhancing revenue...
Source: GlobeNewswire
Date: August, 02 2018 06:40
Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018
EAST RUTHERFORD, N.J., July 27, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that second quarter 2018 financial results will be released on Thursday, August 2...
Source: GlobeNewswire
Date: July, 27 2018 11:10
Blog Exposure - Cambrex Announces Halo Pharma Acquisition
Stock Monitor: IntelliPharmaCeutics Intl. Post Earnings Reporting LONDON, UK / ACCESSWIRE / July 25, 2018 / If you want access to our free research report on Cambrex Corp. (NYSE: CBM ), all you need to do is sign up now by clicking the following link www.active-investors.com/registr...
Source: ACCESSWIRE IA
Date: July, 25 2018 07:20
Cambrex (CBM) To Acquire Halo Pharma For $425M - Slideshow
The following slide deck was published by Cambrex Corporation in conjunction with this Read more ...
Source: SeekingAlpha
Date: July, 23 2018 12:50
Cambrex to acquire Halo Pharma
Cambrex Corporation (NYSE: CBM ) has entered into a definitive agreement to acquire Halo Pharma, a leading dosage form Contract Development and Manufacturing Organization. More news on: Cambrex Corporation, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: July, 23 2018 07:36
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
-- Conference Call at 8:30 a.m. ET Today -- EAST RUTHERFORD, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced it has entered into a definitive...
Source: GlobeNewswire
Date: July, 23 2018 06:40
Is Excelixis A Better Biotech Stock Than Ligand Pharmaceuticals?
Here is what big-money investors now see for coming prices of many Semiconductor competitors This article has no detailed fundamentals-analysis content. All of that analysis has been done by the information-gathering world-wide staffs of the Market-Making [MM] firms, instantaneously commun...
Source: SeekingAlpha
Date: June, 25 2018 16:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0866.1066.9567.2065.85190,496
2018-05-1748.0048.0048.2547.85315,608
2017-11-0848.9546.5049.2045.151,515,418
2017-11-0742.7549.4549.7542.751,213,949
2017-11-0644.1542.6544.7142.55742,749

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-072,0986,00234.9550Cover
2018-12-061,16538,1583.0531Cover
2018-12-045,68221,89025.9571Cover
2018-12-031,4794,66631.6974Cover
2018-11-304601,77325.9447Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CBM.


About Cambrex Corp. (NYSE: CBM)

Logo for Cambrex Corp. (NYSE: CBM)

Not available

 

Contact Information

 

 

Current Management

  • James A. Mack / CEO
  • Claes Glasell / President, COO
  • Salvatore Guccione / CFO
  • Peter E. Thauer / Secretary

Current Share Structure

  • Market Cap: $1,582,055,568 - 05/11/2018
  • Issue and Outstanding: 32,959,491 - 05/01/2018

 


Recent Filings from (NYSE: CBM)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 19 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 16 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 08 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 05 2018

 

 


Daily Technical Chart for (NYSE: CBM)

Daily Technical Chart for (NYSE: CBM)


Stay tuned for daily updates and more on (NYSE: CBM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: CBM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CBM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CBM and does not buy, sell, or trade any shares of CBM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/